Conduit Pharmaceuticals Inc. financial data

Symbol
CDT, CDTTW on Nasdaq
Industry
Pharmaceutical Preparations
Location
4851 Tamiami Trail North, Suite 200, Naples, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
Murphy Canyon Acquisition Corp. (to 9/21/2023)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 39.5 % -47.1%
Debt-to-equity -202 % -68%
Return On Equity 334 % +619%
Return On Assets -329 % -154%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 103M shares
Common Stock, Shares, Outstanding 96M shares +31.9%
Entity Public Float 23.2M USD -82.5%
Common Stock, Value, Issued 10K USD +42.9%
Weighted Average Number of Shares Outstanding, Basic 87.2M shares +33.2%
Weighted Average Number of Shares Outstanding, Diluted 87.2M shares +31.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.09M USD
General and Administrative Expense 11M USD +138%
Operating Income (Loss) -14.3M USD -217%
Nonoperating Income (Expense) -816K USD -654%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.14M USD -49.1%
Income Tax Expense (Benefit) 213K USD +616%
Net Income (Loss) Attributable to Parent -15.2M USD -249%
Earnings Per Share, Basic -0.18 USD/shares -275%
Earnings Per Share, Diluted -0.24 USD/shares -800%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 71K USD -99.2%
Other Assets, Current 51K USD
Assets, Current 1.4M USD -86.6%
Property, Plant and Equipment, Net 48K USD
Operating Lease, Right-of-Use Asset 292K USD
Intangible Assets, Net (Excluding Goodwill) 5K USD
Assets 2.99M USD -75.1%
Accounts Payable, Current 1.9M USD +5314%
Employee-related Liabilities, Current 40K USD -88.2%
Accrued Liabilities, Current 24.5K USD -82.3%
Liabilities, Current 12M USD +160%
Operating Lease, Liability, Noncurrent 110K USD
Liabilities 12.1M USD -7.54%
Accumulated Other Comprehensive Income (Loss), Net of Tax 271K USD -57.6%
Retained Earnings (Accumulated Deficit) -26.7M USD -131%
Stockholders' Equity Attributable to Parent -9.12M USD -743%
Liabilities and Equity 2.99M USD -75.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.36M USD -19.6%
Net Cash Provided by (Used in) Financing Activities 2.22M USD -98.4%
Net Cash Provided by (Used in) Investing Activities -243K USD +99.8%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 96M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.38M USD -29900%
Interest Paid, Excluding Capitalized Interest, Operating Activities 80K USD
Deferred Tax Assets, Valuation Allowance 1.45M USD +585%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.43 pure
Deferred Tax Assets, Gross 1.45M USD +585%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.5M USD -303%
Operating Lease, Liability, Current 147K USD
Deferred Tax Assets, Operating Loss Carryforwards 813K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 17.3M USD +76.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 10K USD
Interest Expense 100K USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%